UK Govt Launches Final Call on Pet Ectoparasitides, Fipronil and Imidacloprid, over Environmental Concerns

Veterinary Medicines Directorate of UK Investigates Restriction of Fipronil and Imidacloprid Products to Veterinary Practitioners Only, This has potential to impact OTC Sales of these molecules commonly used in Pet Spot-Ons. This action may also find reverberations in EU and eventually potentially globally. 

London, United Kingdom — One of the most active regulatory stories in the pet health industry is reaching a critical juncture as the UK government’s Veterinary Medicines Directorate (VMD) closes its Call for Evidence on veterinary medicines containing fipronil and imidacloprid on June 11, 2026, at 23:59.

The industry is now in the final stretch of responding to what could become a landmark regulatory decision reshaping how pet ectoparasiticides are distributed and sold across the United Kingdom.

Regulatory Proposal – What’s Under Investigation

UK government ministers are currently examining whether pet ectoparasiticide products containing fipronil and imidacloprid—which can currently be sold anywhere without professional advice—should be restricted to distribution only through veterinary practitioners or pharmacists.